ANN ARBOR, MI--(Marketwire - August 19, 2008) - Pipex Pharmaceuticals, Inc. (AMEX: PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of central nervous system and autoimmune diseases, today announced that its Chief Executive Officer, Nicholas Stergis, will deliver a financial presentation to investors at the RedChip Emerging Markets Investor Conference on August 21st at the New York Marriott Marquis, located at 1535 Broadway, at 9:30am EDT. The investor conference will be held 8 a.m. to 5 p.m. and Mr. Stergis will be available throughout the day to meet with investors.
